Live Cell Encapsulation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Polymer Type (Alginate, Chitosan, Cellulose Sulphate and Others), By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics), By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow), By Region

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Live Cell Encapsulation Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Polymer Type (Alginate, Chitosan, Cellulose Sulphate and Others), By Application (Drug Delivery, Regenerative Medicine, Cell Transplantation and Probiotics), By Technique (Simple Dripping, Electrostatic Dripping and Coaxial Airflow), By Region

Live Cell Encapsulation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research & development in improving the effectiveness of cell encapsulation technologies, along with the rise in governmental and private investments supporting live cell encapsulated product development.

Live cell encapsulation is a bioengineering technology which includes encasing living cell with a material or coating. A distinct variety of materials are used for the encapsulation such as liposomes, hydrogels, and microcapsules.

Moreover, live cell encapsulation is found to have significant importance in cell therapies as it allows a controlled release of bioactive material or cells, and thereby is anticipated to bolster the market growth with rise in cell therapies across the globe.

Increase in Cell Therapies

The live cell encapsulation delivers the medicinal cell component or bioactive materials in a controlled manner and thus is efficient to be used in cell therapies as they include the delivery of therapeutics directly in the targeted location in the body. Additionally, they do not create any response by the body’s immune system and thus aren’t attacked or eliminated by the immune system. The encapsulates cells in cases carry out specific functions such as activating cancer drugs. For instance, in 2021, a company Nuvilex performed a research study in which the live cells were encapsulated within beads to treat pancreatic cancer. It was observed the cells converted the inactive cancer drug ifosfamide into its cancer-killing form and this specific property ensures the delivery of the chemotherapeutic drug directly to the tumor and thereby is found to have potential usage in the future.

Rising Prevalence of Chronic Disease

According to the report by the International Diabetes Foundation, in 2021 round 537 million adults were affected by diabetes, and it is expected to increase to 643 million by 2030, and by 2045, it will reach 783 million

Growing Research & Development to Improve Product Efficacy

Growing expansion of biotechnology with increasing research & development and rising company investments in live cell encapsulation technologies is leading to improvement in the development and clinical efficacy of live cell encapsulation. The growing investment and increased mutual associations to enhance the live cell encapsulation technological application and production by the key market players is further contributing to the growth of global live cell encapsulation market. For instance, In November 2022, a leading supplier of biocompatible materials- BIO INX collaborated with Nanoscribe- a microfabrication technology leader and launched HYDROBIO INX N400- that enables cell encapsulation in high resolution i.e., 3D printing and is especially designed for 3D microfabrication. Additionally, in July 2021, a clinical biotechnology company -PharmaCyte Biotech developed targeted treatments for cancer and diabetes using live-cell encapsulation technique and has commenced the first phase of a two-phase pig study used for investigating live cell encapsulation technology for diabetes treatment. Thus, growing research are providing opportunities for the companies to enhance the live cell encapsulation technique.


MIR Segment1

Market Segmentation

Global Live Cell Encapsulation Market is segmented based on polymer type, application, technique, region and competitive landscape. Based on polymer type, the market is segmented into alginate, chitosan, cellulose sulfate, and others. Based on application, the market is segmented into drug delivery, regenerative medicine, cell transplantation and probiotics. Based on technique, the market is segmented into simple dripping, electrostatic dripping, and coaxial airflow. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc.,Isogen, Diatranz Otsuka Ltd.

Attribute

Details

Base Year

2022

Historical Years

2018 â€“ 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Polymer Type

Application

Technique

Regional Scope

North America; Asia Pacific; Europe; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait

Key Companies Profiled

AUSTRIANOVA, Merck KGaA, Sphere Fluidics Ltd., ViaCyte, Inc., Blacktrace Holdings Ltd. (Dolomite Microfluidics), BIO INX, Living Cell Technologies Ltd., Sigilon Therapeutics, Inc.,Isogen, Diatranz Otsuka Ltd.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.